Hims & Hers Adds Weight-Loss Injections, Stock Soars
Hims(HIMS) schaeffersresearch.com·2024-05-21 02:47
Hims & Hers Health Inc (NYSE:HIMS) stock is soaring today, up 29.4% to trade at $18.85 and earlier hitting a three-year high of $20.11. Today's pop comes after the healthcare platform added GLP-1 injections to its weight-loss services, a compounded and cheap version of Novo Nordisk's (NVO) semaglutide (the active ingredient in popular weight-loss drug Wegovy). Since the start of the year, HIMS is sporting a 110% lead, with the 100-day moving average stepping up as support earlier this month. Options bulls a ...